TR200100068T2 - Fosforlu organik bileşikler ve kullanımları - Google Patents

Fosforlu organik bileşikler ve kullanımları

Info

Publication number
TR200100068T2
TR200100068T2 TR2001/00068T TR200100068T TR200100068T2 TR 200100068 T2 TR200100068 T2 TR 200100068T2 TR 2001/00068 T TR2001/00068 T TR 2001/00068T TR 200100068 T TR200100068 T TR 200100068T TR 200100068 T2 TR200100068 T2 TR 200100068T2
Authority
TR
Turkey
Prior art keywords
organic compounds
formula
phosphorous organic
bactericide
fungicide
Prior art date
Application number
TR2001/00068T
Other languages
English (en)
Inventor
Jomaa Hassan
Original Assignee
Jomaa,Hassan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19831639A external-priority patent/DE19831639C1/de
Priority claimed from DE19843360A external-priority patent/DE19843360A1/de
Application filed by Jomaa,Hassan filed Critical Jomaa,Hassan
Publication of TR200100068T2 publication Critical patent/TR200100068T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N57/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds
    • A01N57/18—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/383—Cycloaliphatic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3886—Acids containing the structure -C(=X)-P(=X)(XH)2 or NC-P(=X)(XH)2, (X = O, S, Se)
    • C07F9/3891—Acids containing the structure -C(=X)-P(=X)(XH)2, (X = O, S, Se)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/59—Hydrogenated pyridine rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/527—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Plant Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Agronomy & Crop Science (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)

Abstract

Genel formül(I) fosforlu organik bilesiklerinin kullanimi: burada B bir formül (II) eter grubu veya bir formül (III) keto grubu arasindan seçilir veya 5 veya 6 üyeli siklik bir bilesiktir. Bulus ayrica bunlarin insanlar veya hayvanlarda virüslere, bakterilere, mantarlara ve parazitlere bagli enfeksiyonlarin terapötik ve profilaktik tedavisi için farmasötik bilesimler hazirlamak üzere kullanimina ve bitkilerde bir fungisit, bakterisit ve herbisit olarak kullanimlarina iliskindir.
TR2001/00068T 1998-07-15 1999-07-09 Fosforlu organik bileşikler ve kullanımları TR200100068T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19831639A DE19831639C1 (de) 1998-07-15 1998-07-15 Phosphororganische Verbindungen und ihre Verwendung
DE19843360A DE19843360A1 (de) 1998-09-22 1998-09-22 Phosphororganische Verbindungen und ihre Verwendung

Publications (1)

Publication Number Publication Date
TR200100068T2 true TR200100068T2 (tr) 2001-06-21

Family

ID=26047426

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/00068T TR200100068T2 (tr) 1998-07-15 1999-07-09 Fosforlu organik bileşikler ve kullanımları

Country Status (22)

Country Link
US (2) US6812224B2 (tr)
EP (1) EP1095050A1 (tr)
JP (1) JP2002520419A (tr)
KR (1) KR20010070962A (tr)
CN (1) CN1309659A (tr)
AP (1) AP2001002051A0 (tr)
AU (1) AU754165B2 (tr)
BR (1) BR9912062A (tr)
CA (1) CA2336143A1 (tr)
EA (1) EA200100143A1 (tr)
EE (1) EE200100027A (tr)
HR (1) HRP20010035A2 (tr)
HU (1) HUP0103481A3 (tr)
ID (1) ID27347A (tr)
IL (1) IL140433A0 (tr)
IS (1) IS5784A (tr)
NO (1) NO20010200L (tr)
PL (1) PL345864A1 (tr)
SK (1) SK662001A3 (tr)
TR (1) TR200100068T2 (tr)
WO (1) WO2000004031A1 (tr)
YU (1) YU2201A (tr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA200100143A1 (ru) * 1998-07-15 2001-06-25 Хассан Йомаа Фосфорорганические соединения и их применение
AU2000231564A1 (en) * 2000-02-18 2001-08-27 Jomaa Pharmaka Gmbh Phosphororganic compounds and the use thereof
DE10014127A1 (de) * 2000-03-22 2001-10-18 Hassan Jomaa Verwendung von phosphororganischen Verbindungen zur Behandlung von Infektionen
WO2001094358A1 (de) * 2000-06-08 2001-12-13 Jomaa Pharmaka Gmbh Phosphororganische hydroamsäurederivate als herbizide
WO2001093872A1 (de) * 2000-06-08 2001-12-13 Jomaa Pharmaka Gmbh Verwendung von phosphororganischen hydroxamsäurederivaten zur herstellung von arzneimitteln
WO2002078714A1 (de) * 2001-03-30 2002-10-10 Jomaa Pharmaka Gmbh Magensaftresistente formulierungen zur applikation von antiinfektiös wirkenden verbindungen, die den 2-c-methylerythrose-4-stoffwechselweg hemmen, sowie ihren salzen und estern
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate
MXPA03006549A (es) * 2003-07-22 2004-03-18 Univ Autonoma Metropolitana Uso de la dapsona como neuroprotector en el infarto cerebral.
US7122700B2 (en) 2004-07-30 2006-10-17 Xerox Corporation Arylamine processes
EP2018864A1 (en) * 2007-07-23 2009-01-28 Biomet Deutschland GmbH Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition
WO2010019511A2 (en) * 2008-08-13 2010-02-18 Targanta Therapeutics Corp. Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
EP2725029A1 (en) * 2012-10-29 2014-04-30 Laboratoire Biodim New antibacterial compounds and biological applications thereof
CN105319355A (zh) * 2014-07-25 2016-02-10 江苏维赛科技生物发展有限公司 敌百虫胶体金试纸条的制备及使用方法
EP3967312A1 (en) 2014-09-12 2022-03-16 UNION therapeutics A/S Antibacterial use of halogenated salicylanilides
CN107106525B (zh) * 2014-10-24 2021-03-19 红山生物医药有限公司 用于抑制单链rna病毒复制的治疗
GB201509326D0 (en) 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
US11419834B2 (en) 2019-02-25 2022-08-23 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH433290A (de) * 1963-05-13 1967-04-15 Monsanto Co Verfahren zur Herstellung von Diorganohalogenphosphinen
US4038311A (en) * 1969-01-14 1977-07-26 Basf Aktiengesellschaft Production of n-(1-alkenyl)-carbamyl chlorides
DE2032712C3 (de) * 1970-07-02 1978-10-19 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von w-Amino-alkanphosphonsäure bzw.- phosphinsäurederivaten
GB1580899A (en) * 1976-07-27 1980-12-10 Fujisawa Pharmaceutical Co Hydroxyaminohydrocarbonphosphonic acid derivatives and production and use thereof
US4087522A (en) 1976-09-08 1978-05-02 Abbott Laboratories Amides of phosphonoacetic acid for treating herpes simplex virus type 1 and 2 infections
US4268503A (en) * 1978-09-14 1981-05-19 Fujisawa Pharmaceutical Co., Ltd. Antibacterial composition
DE3026326A1 (de) 1980-07-11 1982-02-11 Bayer Ag, 5090 Leverkusen N-phosphonylcarbonyl-carbamate, verfahren zu ihrer herstellung, diese verbindungen enthaltende schaedlingsbekaempfungsmittel und ihre verwendung zur schaedlingsbekaempfung
US4579691A (en) * 1983-04-21 1986-04-01 Ciba-Geigy Corporation Haloacylaminoalkylphosphonates
US4693742A (en) * 1983-12-20 1987-09-15 Rohm And Hass Company Herbicidal hydroxyamino phosphonic acids and derivatives
US4646298A (en) * 1984-05-01 1987-02-24 Texas Instruments Incorporated Self testing data processing system with system test master arbitration
JPS61106504A (ja) * 1984-10-30 1986-05-24 Teijin Ltd 除草剤
US4679691A (en) * 1985-08-12 1987-07-14 Halloran Kevin J Three-sided tip tray
GB8911017D0 (en) 1989-05-13 1989-06-28 Ciba Geigy Ag Substituted aminoalkylphosphinic acids
GB8912814D0 (en) 1989-06-03 1989-07-19 Ciba Geigy Ag P-substituted propane-phospinic acid compounds
CZ288492B6 (en) 1990-04-24 2001-06-13 Biota Scient Management Derivatives of alpha-D-neuraminic acid, process of their preparation, their use and pharmaceutical preparations based thereon
DE4028046A1 (de) 1990-09-05 1992-03-12 Bayer Ag Arzneimittel enthaltend substituierte 2-cyclohexen-1-yl-amin-derivate und ihre verwendung zur bekaempfung von krankheiten
EP0923585B1 (en) 1996-07-18 2002-05-08 Pfizer Inc. Phosphinate based inhibitors of matrix metalloproteases
US6753324B2 (en) * 1998-07-15 2004-06-22 Hassan Jomaa Phosphorous organic compounds and their use
EA200100143A1 (ru) * 1998-07-15 2001-06-25 Хассан Йомаа Фосфорорганические соединения и их применение

Also Published As

Publication number Publication date
ID27347A (id) 2001-04-05
CN1309659A (zh) 2001-08-22
JP2002520419A (ja) 2002-07-09
SK662001A3 (en) 2001-10-08
HUP0103481A3 (en) 2003-01-28
AP2001002051A0 (en) 2001-03-31
IS5784A (is) 2000-12-21
EE200100027A (et) 2002-06-17
NO20010200D0 (no) 2001-01-12
YU2201A (sh) 2003-01-31
EA200100143A1 (ru) 2001-06-25
AU754165B2 (en) 2002-11-07
NO20010200L (no) 2001-03-14
US20030045746A1 (en) 2003-03-06
CA2336143A1 (en) 2000-01-27
HRP20010035A2 (en) 2001-12-31
US6812224B2 (en) 2004-11-02
AU5158099A (en) 2000-02-07
KR20010070962A (ko) 2001-07-28
PL345864A1 (en) 2002-01-14
IL140433A0 (en) 2002-02-10
HUP0103481A2 (en) 2002-06-29
WO2000004031A1 (de) 2000-01-27
US20050075511A1 (en) 2005-04-07
BR9912062A (pt) 2001-04-03
EP1095050A1 (de) 2001-05-02

Similar Documents

Publication Publication Date Title
TR200100068T2 (tr) Fosforlu organik bileşikler ve kullanımları
ATE268544T1 (de) Agrotechnische formulierung
MXPA04005802A (es) Derivados sustituidos de fenilo.
RU94046416A (ru) Производные триазола, способы их получения, инсектицид и акарицид
MXPA02006051A (es) Compuestos de amonio cuaternario ciclico.
NO20015368L (no) Anvendelse av forbindelser omfattende en nitrogen-oksygen- heteroring
BR9916850A (pt) Uso de bisfosfonatos para a profilaxia e tratamento de processos infecciosos
TR200101832T2 (tr) Organofosfor terkipleri ve bunların kullanılmaları.
AP2001002165A0 (en) Use of phosphonoformic acid derivatives for treating infections
AP2001002106A0 (en) Use of organophosphorus compounds for producing medicaments for the therapeutic and prophylactic treatment of infections or as a fungicide, bactericide or herbicide.
TR200102151T2 (tr) Enfeksiyonların profilaktik ve terapötik tedavisinde organofosfor bileşimlerin kullanımı.
EA200100584A1 (ru) Фосфорорганические соединения и их применение
CO5210940A1 (es) Compuestos plaguicidas derivados de pirimidina y composiciones que los contienen
BG101058A (bg) Нафтохинонови производни
DE50011755D1 (de) Alpha-phenyl-beta-ketosulfone
WO2003017766A3 (de) Herbizide auf basis von substituierten arylketonen
NO20012540L (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
SE8702422D0 (sv) Improvements in or relating to fungicides
NO20013464L (no) Anvendelse av 3-isoksazolidinoner og hydroksylaminsyrer for behandling av infeksjoner
HRP20070441T3 (hr) Farmaceutska kombinacija za liječenje grčeva i/ili boli
WO2001049668A3 (de) 4-aryl-1-difluormethoxyimidazole und deren verwendung als herbizide
EE200200315A (et) Kvaternaarsed ammoniumiühendid ja nende kasutamine köhavastase ainena
TH61369A (th) สารผสมต้านแบคทีเรีย